IP Verse

Kraus patent opposition analysis

The comprehensive analysis of Kraus opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Kraus

Stay updated with the latest patent oppositions filed by Kraus

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4370650
Method For Isolating Proteins And Saccharides From YeastYEASTUPJan 15, 2026KRAUS & LEDERER PARTGMBB
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026KRAUS & LEDERER PARTGMBB
EP3256113
Treatment Of HypoparathyroidismENTERA BIODec 29, 2025KRAUS & LEDERER PARTGMBB
EP3470400
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforCRYSTAL PHARMACEUTICAL SUZHOUDec 23, 2025SANDOZ
EP3802639
Propylene-Ethylene Random Copolymers With Low Xs/Et Ratio And High MfrW R GRACE & CONNNov 19, 2025KRAUS & LEDERER PARTGMBB
EP3800177
Fenfluramine Compositions And Methods Of Preparing The SameZOGENIXOct 23, 2025SANDOZ
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 12, 2025TEVA PHARMACEUTICALS
EP3321270
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025KRAUS & LEDERER PARTGMBB
EP3135287
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025TEVA PHARMACEUTICALS
EP4072301
Nanoemulsion For Oral UseNICOVENTURESAug 5, 2025DSM ASSETS

Top clients of Kraus

Top companies who are the clients of Kraus

CompanyTotal
KRAUS & LEDERER PARTGMBB67
SANDOZ28
TEVA PHARMACEUTICALS27
DSM NUTRITIONAL PRODUCTS16
HEXAL6
STADA ARZNEIMITTEL4
ALFASIGMA4
LUYE PHARMA SWITZERLAND3
SANOVEL IIAC SAN VE TIC3
DSM ASSETS3